Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes
Ngotho P. et al, (2025), Plos Pathogens, 21
Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.
Kinyua AW. et al, (2024), J Infect, 89
R21/Matrix-M Protects Against Dermal but not Against Venous Parasites in Human Challenge Studies
Kapulu MC. et al, (2024)
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life Sci Alliance, 7
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya (SERVE-Kenya): A study protocol
Chi PC. et al, (2024), Wellcome Open Research, 9, 193 - 193
Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.
Kapulu M. et al, (2024), Biologicals, 85
Controlled Human Malaria Infection Studies in Africa-Past, Present, and Future.
Kibwana E. et al, (2024), 445, 337 - 365
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
Cavaleri M. et al, (2024), Biologicals
Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya.
Downs LO. et al, (2023), J Virus Erad, 9
The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study.
Kariuki SN. et al, (2023), Elife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Sci Transl Med, 15
Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022.
Barnes MVC. et al, (2023), Immunother Adv, 3
Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL. et al, (2023), Expert Rev Vaccines, 22, 964 - 1007